-
Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides.
Arthritis Rheum. 1988 Jun;31(6):784-8
PMID: 3260102
-
Effect of indomethacin treatment upon actively-induced and transferred experimental allergic encephalomyelitis (EAE) in Lewis rats.
Clin Exp Immunol. 1982 Aug;49(2):386-92
PMID: 6982136
-
Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells.
J Exp Med. 1984 Aug 1;160(2):618-23
PMID: 6332168
-
The immunopathology of experimental allergic encephalomyelitis. II. Endothelial cell Ia increases prior to inflammatory cell infiltration.
J Immunol. 1984 May;132(5):2402-7
PMID: 6425402
-
Evidence for functional heterogeneity of rat CD4+ T cells in vivo. Differential expression of IL-2 and IL-4 mRNA in recipients of cardiac allografts.
J Immunol. 1992 Mar 1;148(5):1308-14
PMID: 1347048
-
Evidence that therapeutic strategies targeted at CD4+ cells modulate accelerated rejection of cardiac allografts in sensitized rats by different mechanisms.
Transplantation. 1992 Aug;54(2):292-6
PMID: 1353914
-
Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering.
Proc Natl Acad Sci U S A. 1992 Jan 1;89(1):421-5
PMID: 1370356
-
Induction of immunity and oral tolerance with polymorphic class II major histocompatibility complex allopeptides in the rat.
Proc Natl Acad Sci U S A. 1992 Aug 15;89(16):7762-6
PMID: 1502196
-
CD4+ suppressor cells inhibit the function of effector cells of experimental autoimmune encephalomyelitis through a mechanism involving transforming growth factor-beta.
J Immunol. 1991 Feb 15;146(4):1163-8
PMID: 1671402
-
Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. III. Synergistic effect of lipopolysaccharide.
Cell Immunol. 1990 Dec;131(2):302-10
PMID: 1700738
-
Prevention and treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-beta 1.
J Immunol. 1991 May 1;146(9):3012-7
PMID: 1707929
-
Successful treatment of experimental allergic encephalomyelitis with transforming growth factor-beta 1.
J Immunol. 1991 Sep 15;147(6):1792-6
PMID: 1716279
-
Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin antigens: IV. Suppression of chronic relapsing disease in the Lewis rat and strain 13 guinea pig.
Ann Neurol. 1991 Jun;29(6):615-22
PMID: 1716432
-
Oral tolerance in experimental autoimmune encephalomyelitis. III. Evidence for clonal anergy.
J Immunol. 1991 Oct 1;147(7):2155-63
PMID: 1717550
-
Antigen-driven bystander suppression after oral administration of antigens.
J Exp Med. 1991 Oct 1;174(4):791-8
PMID: 1717632
-
Cytokines in the central nervous system of mice during chronic relapsing experimental allergic encephalomyelitis.
Cell Immunol. 1991 May;134(2):505-10
PMID: 1902401
-
Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin.
Proc Natl Acad Sci U S A. 1991 Nov 15;88(22):10252-6
PMID: 1946445
-
Protective effect of transforming growth factor beta 1 on experimental autoimmune diseases in mice.
Proc Natl Acad Sci U S A. 1991 Apr 1;88(7):2918-21
PMID: 2011600
-
Interleukin-4: a prototypic immunoregulatory lymphokine.
Blood. 1991 May 1;77(9):1859-70
PMID: 2018830
-
Elevated levels of endogenous IL-6 in systemic lupus erythematosus. A putative role in pathogenesis.
J Immunol. 1991 Jul 1;147(1):117-23
PMID: 2051017
-
Suppression of adjuvant arthritis in Lewis rats by oral administration of type II collagen.
J Immunol. 1990 Oct 15;145(8):2489-93
PMID: 2120332
-
Biological and clinical aspects of interleukin 6.
Immunol Today. 1990 Dec;11(12):443-9
PMID: 2127356
-
Inhibition of S-antigen induced experimental autoimmune uveoretinitis by oral induction of tolerance with S-antigen.
J Immunol. 1990 Mar 1;144(5):1689-95
PMID: 2137841
-
Interleukin 6 production in the central nervous system during experimental autoimmune encephalomyelitis.
Eur J Immunol. 1990 Jan;20(1):233-5
PMID: 2307176
-
Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins.
J Immunol. 1986 Apr 1;136(7):2348-57
PMID: 2419430
-
Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein and its fragments.
J Immunol. 1988 Jan 15;140(2):440-5
PMID: 2447178
-
Suppression of experimental autoimmune encephalomyelitis by the oral administration of myelin basic protein.
Cell Immunol. 1988 Apr 1;112(2):364-70
PMID: 2451570
-
Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. II. Suppression of disease and in vitro immune responses is mediated by antigen-specific CD8+ T lymphocytes.
J Immunol. 1989 Feb 1;142(3):748-52
PMID: 2464023
-
Indomethacin augments in vitro proliferative responses of Lewis rat lymphocytes to myelin basic protein. Implications for experimental autoimmune encephalomyelitis.
Cell Immunol. 1989 Jun;121(1):196-212
PMID: 2470519
-
On the cellular source and function of interleukin 6 produced in the central nervous system in viral diseases.
Eur J Immunol. 1989 Apr;19(4):689-94
PMID: 2543584
-
Production and use of neutralizing monoclonal antibodies to rat interleukin-2.
Transplant Proc. 1989 Feb;21(1 Pt 1):994-6
PMID: 2650305
-
Tumor necrosis factor identified in multiple sclerosis brain.
J Exp Med. 1989 Aug 1;170(2):607-12
PMID: 2754393
-
Two types of mouse helper T cell clone. III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays, and monoclonal antibodies.
J Exp Med. 1987 Nov 1;166(5):1229-44
PMID: 2960769
-
Transforming growth factor beta: biochemistry and roles in embryogenesis, tissue repair and remodeling, and carcinogenesis.
Recent Prog Horm Res. 1988;44:157-97
PMID: 3064207
-
Immunoregulatory molecules and IL 2 receptors identified in multiple sclerosis brain.
J Immunol. 1986 May 1;136(9):3239-45
PMID: 3082983
-
Interferon-gamma and Ia antigen are present on astrocytes in active chronic multiple sclerosis lesions.
J Neurol Sci. 1988 Apr;84(2-3):257-64
PMID: 3132537
-
Purification and amino acid sequencing of NAF, a novel neutrophil-activating factor produced by monocytes.
Biochem Biophys Res Commun. 1987 Dec 16;149(2):755-61
PMID: 3322281
-
Suppression of type II collagen-induced arthritis by intragastric administration of soluble type II collagen.
Proc Natl Acad Sci U S A. 1986 Oct;83(19):7443-6
PMID: 3463976
-
Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1.
Proc Natl Acad Sci U S A. 1986 Jun;83(12):4533-7
PMID: 3487091
-
Ia expression by vascular endothelium is inducible by activated T cells and by human gamma interferon.
J Exp Med. 1983 Apr 1;157(4):1339-53
PMID: 6403654
-
Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines.
Proc Natl Acad Sci U S A. 1987 Dec;84(24):9233-7
PMID: 3480540